Published in J Infect Dis on January 15, 2002
Unique endemicity of cryptosporidiosis in children in Kuwait. J Clin Microbiol (2005) 2.84
Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev (2002) 2.67
Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg Infect Dis (2008) 1.55
Identification of the cryptosporidium pig genotype in a human patient. J Infect Dis (2002) 1.36
Cryptosporidium genotype and subtype distribution in raw wastewater in Shanghai, China: evidence for possible unique Cryptosporidium hominis transmission. J Clin Microbiol (2008) 1.21
Molecular characterization of Cryptosporidium isolates from humans and animals in Iran. Appl Environ Microbiol (2006) 1.17
Host-adapted Cryptosporidium spp. in Canada geese (Branta canadensis). Appl Environ Microbiol (2004) 1.08
Detection of cryptosporidium and identification to the species level by nested PCR and restriction fragment length polymorphism. J Clin Microbiol (2005) 1.03
Electrophoretic analysis of genetic variability within Cryptosporidium parvum from imported and autochthonous cases of human cryptosporidiosis in the United Kingdom. Appl Environ Microbiol (2003) 0.81
Gastroenteritis caused by the Cryptosporidium hedgehog genotype in an immunocompetent man. J Clin Microbiol (2013) 0.78
Development of a two-color fluorescence in situ hybridization technique for species-level identification of human-infectious Cryptosporidium spp. Appl Environ Microbiol (2009) 0.77
A multi-locus study of cryptosporidium parasites isolated from patients living in iran, Malawi, Nigeria, the United kingdom, and Vietnam. Iran J Parasitol (2014) 0.75
Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71
Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg Infect Dis (2002) 2.04
Sporadic cryptosporidiosis case-control study with genotyping. Emerg Infect Dis (2004) 1.97
Foodborne cryptosporidiosis: is there really more in Nordic countries? Trends Parasitol (2012) 1.72
Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev (2013) 1.66
Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg Infect Dis (2008) 1.55
Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis (2004) 1.53
Subtypes of Cryptosporidium parvum in humans and disease risk. Emerg Infect Dis (2007) 1.42
Direct comparison of selected methods for genetic categorisation of Cryptosporidium parvum and Cryptosporidium hominis species. Int J Parasitol (2005) 1.38
Cryptosporidium sp. rabbit genotype, a newly identified human pathogen. Emerg Infect Dis (2009) 1.35
A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors. Clin Cancer Res (2014) 1.35
Subtyping Cryptosporidium ubiquitum,a zoonotic pathogen emerging in humans. Emerg Infect Dis (2014) 1.28
Detection and differentiation of Cryptosporidium spp. in human clinical samples by use of real-time PCR. J Clin Microbiol (2010) 1.23
Re-description of Cryptosporidium cuniculus Inman and Takeuchi, 1979 (Apicomplexa: Cryptosporidiidae): morphology, biology and phylogeny. Int J Parasitol (2010) 1.21
Cryptosporidium genotypes and subtypes in lambs and goat kids in Spain. Appl Environ Microbiol (2008) 1.19
Foot and mouth disease in livestock and reduced cryptosporidiosis in humans, England and Wales. Emerg Infect Dis (2003) 1.18
The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J Infect Dis (2002) 1.16
Cryptosporidium viatorum n. sp. (Apicomplexa: Cryptosporidiidae) among travellers returning to Great Britain from the Indian subcontinent, 2007-2011. Int J Parasitol (2012) 1.16
Inferences about the global population structures of Cryptosporidium parvum and Cryptosporidium hominis. Appl Environ Microbiol (2008) 1.15
Case-control study of environmental and social factors influencing cryptosporidiosis. Eur J Epidemiol (2007) 1.14
Molecular evidence for multiple Toxoplasma gondii infections in individual patients in England and Wales: public health implications. Int J Parasitol (2003) 1.08
Foot and mouth disease and cryptosporidiosis: possible interaction between two emerging infectious diseases. Emerg Infect Dis (2003) 1.07
Geographic linkage and variation in Cryptosporidium hominis. Emerg Infect Dis (2008) 1.07
Self-reported diarrhea in a control group: a strong association with reporting of low-pressure events in tap water. Clin Infect Dis (2005) 1.04
Detection of Cryptosporidium species and sources of contamination with Cryptosporidium hominis during a waterborne outbreak in north west Wales. J Water Health (2009) 1.03
Sporadic human cryptosporidiosis caused by Cryptosporidium cuniculus, United Kingdom, 2007-2008. Emerg Infect Dis (2011) 0.97
Assessment of polymorphic genetic markers for multi-locus typing of Cryptosporidium parvum and Cryptosporidium hominis. Exp Parasitol (2012) 0.94
Multi-locus analysis of human infective Cryptosporidium species and subtypes using ten novel genetic loci. BMC Microbiol (2010) 0.94
Zoonotic linkage and variation in Cryptosporidium parvum from patients in the United Kingdom. Parasitol Res (2010) 0.88
Distribution of Cryptosporidium species in sheep in the UK. Vet Parasitol (2008) 0.88
Whole genome amplification (WGA) for archiving and genotyping of clinical isolates of Cryptosporidium species. Parasitology (2009) 0.88
Using a Geographical Information System to investigate the relationship between reported cryptosporidiosis and water supply. Int J Health Geogr (2004) 0.84
Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry. Chem Res Toxicol (2010) 0.84
A new heterogeneous family of telomerically encoded Cryptosporidium proteins. Evol Appl (2012) 0.84
Detection and resolution of Cryptosporidium species and species mixtures by genus-specific nested PCR-restriction fragment length polymorphism analysis, direct sequencing, and cloning. Appl Environ Microbiol (2011) 0.83
Sporadic cryptosporidiosis decline after membrane filtration of public water supplies, England, 1996-2002. Emerg Infect Dis (2005) 0.83
Microsatellite typing of Cryptosporidium parvum in isolates from a waterborne outbreak. J Clin Microbiol (2008) 0.83
Meeting report: Application of genotyping methods to assess risks from cryptosporidium in watersheds. Environ Health Perspect (2006) 0.82
Genotype and subtype analysis of Cryptosporidium isolates from calves and lambs in Galicia (NW Spain). Parasitology (2010) 0.82
Zoonotic cryptosporidiosis from petting farms, England and Wales, 1992-2009. Emerg Infect Dis (2011) 0.82
Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours. Expert Opin Investig Drugs (2007) 0.81
Detection and characterization of Cryptosporidium cuniculus by real-time PCR. Parasitol Res (2012) 0.81
Novel VEGF signalling inhibitors: how helpful are biomarkers in their early development? Expert Opin Investig Drugs (2009) 0.81
Identification and molecular characterization of Cryptosporidium and Giardia in children and cattle populations from the province of Álava, North of Spain. Sci Total Environ (2011) 0.80
The CpA135 gene as a marker to identify Cryptosporidium species infecting humans. Parasitol Int (2010) 0.80
Population structure of natural and propagated isolates of Cryptosporidium parvum, C. hominis and C. meleagridis. Environ Microbiol (2014) 0.80
An improved 'cold SSCP' method for the genotypic and subgenotypic characterization of Cryptosporidium. Mol Cell Probes (2004) 0.80
Six weeks of home enteral nutrition versus standard care after esophagectomy or total gastrectomy for cancer: study protocol for a randomized controlled trial. Trials (2014) 0.79
Identification of Cryptosporidium xiaoi in diarrhoeic goat kids (Capra hircus) in Spain. Vet Parasitol (2010) 0.79
Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial. Cancer Chemother Pharmacol (2014) 0.78
Universal extraction method for gastrointestinal pathogens. J Med Microbiol (2013) 0.78
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI), in patients with advanced solid tumours. Cancer Chemother Pharmacol (2009) 0.78
Cryptosporidium: from molecules to disease. Trends Parasitol (2002) 0.77
Validation of fragment analysis by capillary electrophoresis to resolve mixed infections by Cryptosporidium parvum subpopulations. Parasitol Res (2014) 0.76
Survey of Cryptosporidium parvum genotypes in humans from the UK by mutation scanning analysis of a heat shock protein gene region. Mol Cell Probes (2003) 0.76
Speciation of oxaliplatin adducts with DNA nucleotides. Metallomics (2011) 0.76
Prevalence of Cryptosporidium Carriage and Disease in Children With Primary Immune Deficiencies Undergoing Hematopoietic Stem Cell Transplant in Northern Europe. Pediatr Infect Dis J (2017) 0.75
Prevalence of Cryptosporidium Carriage and Disease in Children with Primary Immune-Deficiencies Undergoing Hematopoietic Stem Cell Transplant in Northern Europe. Pediatr Infect Dis J (2016) 0.75
Detection of IgG antibodies in sera from patients with Cryptosporidium parvum and Cryptosporidium hominis. J Infect (2013) 0.75
Assessing barriers to a rational chemoprevention trial design in young patients with familial adenomatous polyposis. Eur J Cancer Prev (2017) 0.75
A feasibility study of the use of saliva as an alternative to leukocytes as a source of DNA for the study of Pt-DNA adducts in cancer patients receiving platinum-based chemotherapy. Anal Bioanal Chem (2014) 0.75
Cyclospora infection linked to travel to Mexico, June to September 2015. Euro Surveill (2015) 0.75